Recent Blog Articles
Children not yet vaccinated against COVID-19? What to do
HIV rates rising: Could new forms of PrEP help?
Careful! Scary health news can be harmful to your health
Post-pandemic weight loss: There’s an app for that
Cognitive behavioral therapy for insomnia by telemedicine: Is it as good as in-person treatment?
Prediabetes diagnosis as an older adult: What does it really mean?
Is blood sugar monitoring without diabetes worthwhile?
Large review study finds low risk of erectile dysfunction after prostate biopsy
Does exercise help protect against severe COVID-19?
A new Alzheimer’s drug has been approved. But should you take it?
Amy C. Sherman, MD
Amy Sherman, MD, is an instructor in medicine at Harvard Medical School, associate physician in the division of infectious diseases at Brigham and Women’s Hospital, and a clinician-scientist with the Precision Vaccines Program. Her research focuses on immune responses to vaccination, and she has been a co-investigator in Phase 3 COVID-19 vaccine trials for the Moderna and Janssen Biotech (Johnson & Johnson) vaccines.